Jennifer Ruddock currently serves as Chief Business Officer leading corporate and business development and corporate strategy for Nektar.  She also oversees and leads investor relations, corporate communications, and public and government affairs functions. Ms. Ruddock’s professional experience spans over 25 years in biotechnology, technology and finance. Prior to joining Nektar, Ms. Ruddock held leadership roles at multiple public companies, including Catellus Development Corporation (acquired by ProLogis) and Tumbleweed Communications (acquired by Axway). Prior to that, she was at Montgomery Securities (acquired by Bank of America), a San Francisco-based investment bank which specialized in technology and healthcare sectors.

Ms. Ruddock serves on the Board of Directors of Gannet BioChem, a leading specialty chemical CDMO, the California Life Sciences Association (CLSA), and is a member of the Public Policy Committee of the San Francisco Chamber of Commerce. She is also a board member of the San Francisco Foster Youth Fund, a non-profit providing educational grants to at-risk youth in San Francisco foster care.

Ms. Ruddock received her B.A. degree in neuroscience from Colgate University in 1991.